Health
Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study – Sports Grind Entertainment
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according…
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according to a new study.
Called baricitinib, and marketed under the brand name Olumiant, the medication has been touted by its British company as a possible game changer in the fight against COVID-19, the Daily Mail reported.
The rheumatoid arthritis drug, which has been available for only three years, was identified in February as a strong candidate…
-
Noosa News16 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoAbout 90,000 households remain without power after severe storms with giant hail lash south-east Queensland
-
General19 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility
-
General17 hours agoLabor to squeeze public service, sparking warnings of job losses